NewsRx

Search our medical news database

InNexus Biotechnology Inc.

InNexus Biotechnology Receives 2008 Frost & Sullivan Innovation of the Year Award

Published in Healthcare Mergers, Acquisitions and Ventures Week, May 24th, 2008

InNexus Biotechnology Inc. (OTCBB:IXSBF) (TSX VENTURE:IXS) (www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies, announced that it has been awarded the 2008 Frost & Sullivan Therapeutic Monoclonal Antibodies Technology Innovation of the Year Award for its Dynamic Cross Linking (DXL(TM)) technology.

"We are pleased to accept this award for our DXL(TM) technology and anticipate many new innovative products to emerge in the near future from this technology," said Jeff Morhet, CEO and Chairman of InNexus Biotechnology.

Pablo Legorreta, Chief Executive Officer of Royalty Pharma stated, "I'm pleased with...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook